{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP02863",
    "Peptide Name": "K11 (Lys-rich; synthetic AMPs20, hybrid peptide, UCLL1c)",
    "Source": "hybrid peptide, combined melittin, cecropin A1 and magainin 2 fragments, designed, man-made sequences",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "KWKSFIKKLTKKFLHSAKKF",
    "Sequence Length": 20,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Anti-MRSA",
      "Wound healing"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 9,
    "Boman Index": 1.52,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "40%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "APD analysis reveals that the sequence of this peptide shows 75% similarity toCE-MA hybrid.  A hybrid of melittin, cecropin A1 and magainin 2. Active against Gram+ S. aureus CMCC26003 or MRSA (MIC 0.25-4 ug/mL), B. subtilis DB430 (MIC 2 ug/mL), S. epidermidis (MIC 0.5-8 ug/ml), B. pumilus CMCC63202 (MIC 0.5 ug/mL),  M. luteus CMCC28001 (MIC 2 ug/mL), Gram- E. coli ATCC8099 (MIC 0.5 ug/mL), K. pneumoniae CMCC46117 or clinical (MIC 0.5-4 ug/mL), S. paratyphi B CMCC50094 (MIC 2 ug/mL), P. aeruginosa CMCC10104 (MIC 1-8 ug/mL).Animal model:mouse: K11 also showed efficacy in wound healing (Rishi et al., 2018). Updated 7/2021",
    "Author": "Jin-Jiang H1, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",
    "Reference": "Int J Microbiol. 2012;2012:764834. doi: 10.1155/2012/764834.PubMed",
    "Title": "The Design and Construction of K11: A Novel alpha-Helical Antimicrobial Peptide"
  },
  "3D Structure": []
}